By correlating receptor activity with healing outcomes and clinical variables such as PD duration and medication use, this study would clarify whether NMDAR and EGFR dysregulation contributes to impaired wound healing in PD and assess the influence of neurodegeneration on peripheral tissue repair. The gene discussed is EGFR; the disease is Parkinson disease.